Theranos Gets Rid of 41% of Staff

By MedTech Intelligence Staff
No Comments

The company is eliminating 155 positions.

As if things couldn’t get worse for Theranos, the news came today that the company is cutting nearly 41% of its positions (155 employees), with only 220 staff remaining. According to Bloomberg those employees who remain will work on Theranos’ minilab product, which has not yet received the seal of approval from FDA.

Theranos laid off 340 employees last October, and back in July CMS banned the company’s CEO Elizabeth Holmes from operating any lab for two years (Read the list of CMS sanctions against Theranos).

Related Articles

About The Author

MedTech Intelligence

Leave a Reply

Your email address will not be published. Required fields are marked *

For security, use of Google's reCAPTCHA service is required which is subject to the Google Privacy Policy and Terms of Use.

I agree to these terms.